Cleared Traditional

K050989 - AWQ-104

K050989 is an FDA 510(k) clearance for AWQ-104, manufactured by Lhasa Oms, Inc.. The device is a Class 2 Neurology device with product code GZJ cleared through the Traditional 510(k) pathway after a 352-day FDA review.

K050989 · Lhasa Oms, Inc. · Neurology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 2006
Decision
352d
Days
Class 2
Risk

K050989 is an FDA 510(k) clearance for the AWQ-104. Classified as Stimulator, Nerve, Transcutaneous, For Pain Relief (product code GZJ), Class II - Special Controls.

Submitted by Lhasa Oms, Inc. (Weymouth, US). The FDA issued a Cleared decision on April 6, 2006 after a review of 352 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.5890 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Elevated predicate reliance profile. This clearance follows a standard predicate-based equivalence path within the Neurology review framework, consistent with the majority of Class II 510(k) submissions.

View all Lhasa Oms, Inc. devices

FDA 510(k) Submission Details - K050989

510(k) Number K050989 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 19, 2005
Decision Date April 06, 2006
Days to Decision 352 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
203d slower than avg
Panel avg: 149d · This submission: 352d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

GZJ Device Classification - Class 2, Special Controls

Product Code GZJ Stimulator, Nerve, Transcutaneous, For Pain Relief
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.5890
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - GZJ Stimulator, Nerve, Transcutaneous, For Pain Relief

All 350
Devices cleared under the same product code (GZJ) and FDA review panel - the closest regulatory comparables to K050989.
POINTER PLUS
K060508 · Lhasa Oms, Inc. · Jun 2006
POINTER EXCEL
K060517 · Lhasa Oms, Inc. · Jun 2006
INFREX
K060246 · Johari Digital Healthcare , Ltd. · May 2006
INSPIRSTAR IS02 MICROCURRENT STIMULATOR
K060368 · Inspirstar, Inc. · Mar 2006
ELECTROPULSE
K051128 · Pain Relief Technologies · Mar 2006
MAGBODY DT-600
K053284 · Durtech System Corp. · Mar 2006